Friday, April 19, 2024
4/19/2024
The overall purpose of the Connecticut Strategic Prevention Framework for Prescription Drugs (CT SPF Rx) 2021 initiative is to reduce the non-medical use of prescription drugs and prevent opioid overdoses via strategies that: increase public awareness and education of the dangers of prescription drug misuse; increase the capacity to understand and use Prescription Drug Monitoring Program (PDMP) data; and, build partnerships among stakeholders to expand resources and diffuse best practices across the state. Graduate students from the health profession programs at the University of Connecticut will be placed in health districts and departments which are burdened with health related tasks. A subset of the State Epidemiological and Outcomes Workgroup (SEOW) comprised of an interdisciplinary panel of stakeholders will be convened to review PDMP data for trends and applications of the data and make recommendations to address data gaps. The Prevention Subcommittee of the Alcohol and Drug Policy Council, with its broad representation of agencies and individuals with interests and resources in prescription drugs/opioid overdose prevention issues, will serve as the advisory council for the grant and help diffuse successful practices from the grant to other communities across the state. Evaluation using data gathered will be conducted at the state and community levels to track whether performance measures and objectives are being met and any needed adjustments. It is anticipated that by the end of the grant, approximately 1,016,688 individuals would be seen, experienced or otherwise impacted by interventions implemented in funded communities.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
